Molina Healthcare, Inc (NYSE:MOH) Shares Bought by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. lifted its holdings in Molina Healthcare, Inc (NYSE:MOH) by 4.5% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,841 shares of the company’s stock after purchasing an additional 296 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Molina Healthcare were worth $2,209,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in MOH. Smartleaf Asset Management LLC grew its holdings in shares of Molina Healthcare by 123.9% in the 4th quarter. Smartleaf Asset Management LLC now owns 347 shares of the company’s stock worth $100,000 after acquiring an additional 192 shares during the last quarter. Farther Finance Advisors LLC increased its stake in Molina Healthcare by 100.3% in the 1st quarter. Farther Finance Advisors LLC now owns 659 shares of the company’s stock worth $216,000 after purchasing an additional 330 shares in the last quarter. Raymond James Financial Inc. purchased a new position in Molina Healthcare in the 4th quarter worth about $10,725,000. US Bancorp DE raised its holdings in Molina Healthcare by 22.3% during the 4th quarter. US Bancorp DE now owns 1,993 shares of the company’s stock worth $580,000 after buying an additional 364 shares during the period. Finally, Wealth Enhancement Advisory Services LLC lifted its stake in Molina Healthcare by 82.1% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 15,635 shares of the company’s stock valued at $5,150,000 after buying an additional 7,051 shares in the last quarter. 98.50% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Molina Healthcare

In other news, CEO Joseph M. Zubretsky sold 87,500 shares of the business’s stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the transaction, the chief executive officer owned 257,715 shares in the company, valued at approximately $82,484,262.90. The trade was a 25.35% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Richard M. Schapiro sold 669 shares of the company’s stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total transaction of $214,414.50. Following the transaction, the director directly owned 11,244 shares of the company’s stock, valued at $3,603,702. This represents a 5.62% decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.10% of the company’s stock.

Molina Healthcare Price Performance

NYSE MOH opened at $239.51 on Friday. Molina Healthcare, Inc has a 1 year low of $236.37 and a 1 year high of $365.23. The company has a fifty day simple moving average of $303.76 and a 200 day simple moving average of $305.83. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.87. The company has a market cap of $12.98 billion, a P/E ratio of 11.56, a P/E/G ratio of 0.80 and a beta of 0.55.

Molina Healthcare (NYSE:MOH) last released its earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.96 by $0.12. Molina Healthcare had a return on equity of 28.38% and a net margin of 2.81%. The firm had revenue of $11.15 billion for the quarter, compared to analyst estimates of $10.86 billion. During the same quarter last year, the firm posted $5.73 EPS. The company’s revenue was up 12.2% on a year-over-year basis. On average, sell-side analysts predict that Molina Healthcare, Inc will post 24.4 EPS for the current year.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the stock. Robert W. Baird reissued a “neutral” rating and issued a $375.00 target price (up from $331.00) on shares of Molina Healthcare in a research report on Tuesday, April 15th. Baird R W lowered Molina Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, April 15th. Barclays decreased their target price on Molina Healthcare from $351.00 to $347.00 and set an “equal weight” rating for the company in a research report on Monday, June 9th. Mizuho raised their price objective on Molina Healthcare from $376.00 to $400.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 9th. Finally, Sanford C. Bernstein initiated coverage on shares of Molina Healthcare in a research report on Tuesday, April 22nd. They set an “outperform” rating and a $414.00 price objective on the stock. Ten analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $364.21.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.